The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China.
Thromb J
; 20(1): 56, 2022 Sep 27.
Article
en En
| MEDLINE
| ID: mdl-36167545
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Thromb J
Año:
2022
Tipo del documento:
Article
País de afiliación:
China